Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23710117 | 0.85 | LMNA (0.47) | LMNAALDH1A1POLBABCC4MAPT | |
| SCHEMBL28957008 | 0.85 | LMNA (0.55) | LMNAALDH1A1POLBABCC4MAPT | |
| SCHEMBL21585320 | 0.84 | DGKA (0.50) | — | |
| SCHEMBL16377281 | 0.79 | LPAR1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL7972731 | 0.77 | LMNA (0.51) | LMNAALDH1A1POLB | |
| SCHEMBL24199430 | 0.77 | LMNA (0.51) | LMNAALDH1A1POLB | |
| SCHEMBL21582227 | 0.77 | DGKA (0.51) | — | |
| SCHEMBL21582228 | 0.77 | DGKA (0.51) | — | |
| SCHEMBL16344559 | 0.77 | DGKA (0.51) | — | |
| SCHEMBL23391308 | 0.74 | MGLL (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210238209-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | EKTAH (FR) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238209-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | FFAR3, FFAR2, FFAR1 | LMNA 2987/4885ALDH1A1 3829/4885POLB 4011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.